Pandozi Claudio, Matteucci Andrea, Pignalberi Carlo, Sgarra Luca, Bonanni Michela, Mariani Marco Valerio, La Fazia Vincenzo Mirco, Nesti Lorenzo, Di Fusco Stefania Angela, Nardi Federico, Colivicchi Furio
Clinical and Rehabilitation Cardiology Division, San Filippo Neri Hospital, 00135 Rome, Italy.
Department of Experimental Medicine, Tor Vergata University, 00133 Rome, Italy.
Antibiotics (Basel). 2024 Oct 18;13(10):991. doi: 10.3390/antibiotics13100991.
Cardiac device infections (CDIs) are a serious complication in patients with implanted devices, resulting in increased morbidity, prolonged hospital stay, and increased healthcare costs. The effective management of these infections involves a combination of appropriate antibiotic therapy and preventive strategies aimed at reducing the risk of infection. The role of antibiotic prophylaxis in infection prevention is crucial, including the emerging use of antibiotic-supported tools and other local antibiotic delivery systems, which may reduce the risk of infection at the device implant site. In this contemporary review, we provide an overview of the prophylactic treatment and different antibiotic regimens for the treatment of CDIs, emphasizing early diagnosis, appropriate choice of antibiotics, and individualized treatment.
心脏装置感染(CDIs)是植入装置患者的一种严重并发症,会导致发病率增加、住院时间延长和医疗费用增加。这些感染的有效管理涉及适当的抗生素治疗和旨在降低感染风险的预防策略的结合。抗生素预防在预防感染中的作用至关重要,包括新兴的抗生素支持工具和其他局部抗生素递送系统的使用,这可能会降低装置植入部位的感染风险。在这篇当代综述中,我们概述了CDIs的预防性治疗和不同的抗生素治疗方案,强调早期诊断、抗生素的适当选择和个体化治疗。